Governance

Building on our values, Lilly embraces the principles of good corporate governance, implemented through strong, independent and diverse membership on our board of directors.

Over the years, we have consistently sought to implement best governance practices. In today's climate of concern over corporate accountability, it is more important than ever that we continually earn investor confidence. We will do this by remaining a leader in good corporate governance and providing clear, consistent and truthful communication about our performance.

By selecting the links below, you may access information about our executive committee, corporate governance principles, other key corporate governance information and our SEC filings. For copies of these documents, call The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979).

Committee Charters

Board of Directors Committee Membership

Member Board of Directors Audit Committee Compensation Committee Directors and Corporate Governance Committee Finance Committee Public Policy and Compliance Committee Science and Technology Committee
John C. Lechleiter, Ph.D. Chair - - - - - -
David A. Ricks Member - - - - - -
Ralph Alvarez Member - Chair - - - Member
Katherine Baicker, Ph.D. Member Member - - - Member -
Carolyn R. Bertozzi, Ph.D. Member - - - - Member Member
Michael L. Eskew Member Chair - Member Member - -
J. Erik Fyrwald Member - - - - Chair Member
R. David Hoover Member - - Member Chair - -
Jamere Jackson Member Member - - Member - -
William G. Kaelin, Jr., M.D. Member - - - Member - Chair
Juan R. Luciano Member - - - Member Member -
Ellen R. Marram Member - Member Chair - - -
Franklyn G. Prendergast, M.D., Ph.D. Member - - - - Member Member
Marschall S. Runge, M.D., Ph.D. Member - - - - Member Member
Kathi P. Seifert Member Member Member - - - -
Jackson Tai Member Member - - Member - -